2277 articles by Nick Paul Taylor
-
Medtronic wins FDA approval for Affera mapping and ablation system
Oct. 25, 2024 -
European Parliament calls for proposals to reform MDR and IVDR by end of Q1
Oct. 24, 2024 -
Hologic to lay off 86 people in closure of Connecticut facility
Oct. 23, 2024 -
Boston Scientific, Edwards and Dexcom usher in second week of earnings
Oct. 22, 2024 -
GE Healthcare opens AI Innovation Lab to grow new projects
Oct. 22, 2024 -
Boston Scientific blood-blocking agent tied to additional 2 deaths, 8 injuries
Oct. 21, 2024 -
FDA prioritizes guidance on lab developed tests in 2025 plan
Oct. 18, 2024 -
Medtech Europe calls for urgent reform of MDR and IVDR
Oct. 18, 2024 -
FDA labels Cue’s recall of COVID tests as Class II, revokes EUAs
Oct. 17, 2024 -
Health officials outline industry role in AI oversight in JAMA article
Oct. 16, 2024 -
Hologic to buy Gynesonics for $350M to acquire fibroid system
Oct. 15, 2024 -
J&J, Abbott and Intuitive kick off latest medtech earnings season
Oct. 14, 2024 -
Abbott enrolls pivotal PFA study 4 months ahead of schedule
Oct. 11, 2024 -
Shiratronics raises $66M for trial of neuromodulation migraine device
Oct. 10, 2024 -
Procept secures FDA approval to study surgical robot in prostate cancer
Oct. 9, 2024 -
Mercury Medical recalls emergency resuscitators
Oct. 8, 2024 -
Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test
Oct. 7, 2024 -
Elucid wins FDA 510(k) nod for heart plaque image analysis software
Oct. 4, 2024 -
FDA authorizes Pi-Cardia’s valve-in-valve TAVR device
Oct. 3, 2024 -
Siemens Healthineers wins FDA approval for 3D mammography system
Oct. 2, 2024 -
Synchron’s brain-computer interface tech meets safety goal
Oct. 1, 2024 -
Establishment Labs wins FDA approval for Motiva breast implants
Sept. 30, 2024 -
Mendaera raises $73M to develop handheld robotics platform
Sept. 27, 2024 -
FDA proposes reclassifying hepatitis B assays
Sept. 26, 2024 -
Roche launches test that detects 12 respiratory viruses
Sept. 25, 2024